Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

New Mexico Enacts Psychedelic Therapy Bill

Senate Bill 219 allows for psilocybin therapy for the treatment of PTSD, treatment-resistant depression, and more.
Read More →
May 12, 2025

WCRI Reports On the Impact Of Marijuana Laws On Workers’ Comp Benefits

While recreational marijuana laws may be tied to increases in claim frequency, medical payments and prescriptions decreased, including those for opioids.
Read More →
May 5, 2025

Wisconsin Workers’ Compensation Advisory Council Meeting Recap

Topics discussed include proposals for a fee schedule by 2027, employer direction of care, and allowing more providers to provide disability opinions.
Read More →
May 5, 2025

Ohio Introduces New Outpatient Rules for Medication Reimbursement

After previous drafts of new rules were withdrawn last year, a revised set of rules have been introduced, based on stakeholder feedback.
Read More →
May 5, 2025

Colorado Stakeholders Debate Over Physician Oversight

In a DWC meeting, stakeholders spoke regarding the timeline of when a physician evaluates a patient, versus other types of providers.
Read More →
May 5, 2025

WCRI Publishes CompScope Benchmarks Report

A total of 14 reports capture workers’ comp data from 2018-2023 for 18 states, with information on medical payments and other metrics.
Read More →
May 5, 2025

WCRI Publishes Annual Report

The report summarizes 2024 activities, including over 40 studies that address topics such as psychosocial factors, attorney involvement, and more.
Read More →
April 28, 2025

Nevada Provider Panel Bill Fails

Assembly Bill 469 missed a committee deadline, removing it from consideration this legislative session.
Read More →
April 28, 2025

Nevada Heat Safety Rules to Take Effect April 29th

Employers with over 10 employees working outdoors, or indoors without climate control, must adhere to the new rules.
Read More →
April 28, 2025
1 … 25 26 27 28 29 … 48

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

AMA Updates Impairment Rating Guidelines for the First Time Since 2008

Changes center around improving the assessment of mental and behavioral impairment.
Read More

More Recreational Marijuana Legalization, More Positive Workplace Drug Tests

Connecticut legalizes recreational use, and NCCI expects even more states to follow suit.
Read More

Interstate Variation and Trends in Workers’ Comp Drug Payments

A new flash report from the WCRI highlights trends in drug utilization.
Read More

Mental Health Injuries Gain Momentum in Workers’ Comp

Corrections officers in Nebraska benefit from a new law; will healthcare workers in Connecticut join them?
Read More

FDA Approves Kloxxado for Opioid Overdose

A new 8 mg naloxone nasal spray will soon be available, which is the largest naloxone dose approved by the FDA to date.
Read More

FDA Revokes Emergency Use Authorization for Bamlanivimab for COVID-19

Due to mutating viral strains, the potential benefits of this COVID-19 drug no longer outweigh the risks.
Read More
1 … 25 26 27 28 29 … 50
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle